Preferred Label : Leukoencephalopathy, brain calcifications, and cysts;
Symbol : LCC;
CISMeF acronym : LCC;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Labrune syndrome;
Description : Leukoencephalopathy, brain calcifications, and cysts (LCC), also known as Labrune
syndrome, is characterized by a constellation of features restricted to the central
nervous system, including leukoencephalopathy, brain calcifications, and cysts, resulting
in spasticity, dystonia, seizures, and cognitive decline (summary by Labrune et al.,
1996). See also cerebroretinal microangiopathy with calcifications and cysts (CRMCC;
612199), an autosomal recessive disorder caused by mutation in the CTC1 gene (613129)
that shows phenotypic similarities to Labrune syndrome. CRMCC includes the neurologic
findings of intracranial calcifications, leukodystrophy, and brain cysts, but also
includes retinal vascular abnormalities and other systemic manifestations, such as
osteopenia with poor bone healing, a high risk of gastrointestinal bleeding, hair,
skin, and nail changes, and anemia and thrombocytopenia. Although Coats plus syndrome
and Labrune syndrome were initially thought to be manifestations of the same disorder,
namely CRMCC, molecular evidence has excluded mutations in the CTC1 gene in patients
with Labrune syndrome, suggesting that the 2 disorders are not allelic (Anderson et
al., 2012; Polvi et al., 2012).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the small nucleolar RNA, C/D box, 118 gene (SNORD118, 616663.0001);
Prefixed ID : #614561;
Origin ID : 614561;
UMLS CUI : C3281200;
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)